Search the Appendices of Resolution CM/Res(2018)1
2416 found
| INN | ATC Code ▲ | Country | Classification | Last update | MA Number | Registration date | Status | |
|---|---|---|---|---|---|---|---|---|
| PIDOTIMOD | L03AX05 | IT | II | None | 16-09-2003 | VALID | ||
| THYMOPENTIN | L03AX09 | IT | II | None | 16-09-2003 | VALID | ||
| GLATIRAMER ACETATE | L03AX13 | IT | II | VALID | ||||
| ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) | L04AA04 | IT | POM | VALID | ||||
| MYCOPHENOLIC ACID | L04AA06 | IT | I | VALID | ||||
| ABATACEPT | L04AA24 | IT | I | 07-11-2019 | VALID | |||
| CLADRIBINE | L04AA40 | IT | I | 21-02-2020 | VALID | |||
| IMLIFIDASE | L04AA41 | IT | I | VALID | ||||
| EFGARTIGIMOD ALFA | L04AA58 | IT | I | 18-11-2022 | EMEA/H/C/005849 | 10-08-2022 | VALID | |
| ETANERCEPT | L04AB01 | IT | II | VALID | ||||
| INFLIXIMAB | L04AB02 | IT | I | VALID | ||||
| ADALIMUMAB | L04AB04 | IT | II | 12-07-2022 | VALID | |||
| CERTOLIZUMAB PEGOL | L04AB05 | IT | II | VALID | ||||
| GOLIMUMAB | L04AB06 | IT | II | VALID | ||||
| DACLIZUMAB | L04AC01 | IT | Not authorised | VALID | ||||
| ANAKINRA | L04AC03 | IT | II | 28-11-2019 | VALID | |||
| SECUKINUMAB | L04AC10 | IT | II | VALID | ||||
| IXEKIZUMAB | L04AC13 | IT | POM | 07-11-2016 | EMEA/H/C/003943 | 25-04-2016 | VALID | |
| GUSELKUMAB | L04AC16 | IT | I | 04-05-2018 | VALID | |||
| TILDRAKIZUMAB | L04AC17 | IT | Not authorised | 15-11-2018 | VALID | |||
| RISANKIZUMAB | L04AC18 | IT | I | 23-01-2020 | VALID | |||
| SATRALIZUMAB | L04AC19 | IT | I | 19-10-2021 | EMEA/H/C/004788 | 24-06-2021 | VALID | |
| BIMEKIZUMAB | L04AC21 | IT | I | 19-10-2021 | EMEA/H/C/005316 | 20-08-2021 | VALID | |
| SPESOLIMAB | L04AC22 | IT | I | 18-08-2023 | EMEA/H/C/005874 | 09-12-2022 | VALID | |
| MIRIKIZUMAB | L04AC24 | IT | I | 14-11-2023 | EMEA/H/C/005122 | 26-05-2023 | VALID | |
| CICLOSPORIN | L04AD01 | IT | I | VALID | ||||
| TACROLIMUS | L04AD02 | IT | I | VALID | ||||
| VOCLOSPORIN | L04AD03 | IT | I | 18-11-2022 | EMEA/H/C/005256 | 15-09-2022 | VALID | |
| FINGOLIMOD | L04AE01 | IT | II | 07-09-2020 | VALID | |||
| OZANIMOD | L04AE02 | IT | I | VALID | ||||
| SIPONIMOD | L04AE03 | IT | I | 05-06-2020 | EMEA/H/C/004712 | 13-01-2020 | VALID | |
| PONESIMOD | L04AE04 | IT | I | 19-10-2021 | EMEA/H/C/005163 | 19-05-2021 | VALID | |
| ETRASIMOD | L04AE05 | IT | I | 13-05-2024 | EMEA/H/C/006007 | 16-02-2024 | VALID | |
| TOFACITINIB | L04AF01 | IT | I | VALID | ||||
| BARICITINIB | L04AF02 | IT | I | 19-07-2023 | VALID | |||
| UPADACITINIB | L04AF03 | IT | I | 05-06-2020 | EMEA/H/C/004760 | 16-12-2019 | VALID | |
| FILGOTINIB | L04AF04 | IT | I | 03-03-2021 | EMEA/H/C/005113 | 24-09-2020 | VALID | |
| DEUCRAVACITINIB | L04AF07 | IT | I | 18-08-2023 | EMEA/H/C/005755 | 24-03-2023 | VALID | |
| RITLECITINIB | L04AF08 | IT | I | 14-11-2023 | EMEA/H/C/006025 | 15-09-2023 | VALID | |
| MUROMONAB-CD3 | L04AG01 | IT | I | None | VALID | |||
| NATALIZUMAB | L04AG03 | IT | POM | 11-10-2017 | VALID | |||
| BELIMUMAB | L04AG04 | IT | I | 09-04-2018 | VALID | |||
| ALEMTUZUMAB | L04AG06 | IT | I | VALID | ||||
| OCRELIZUMAB | L04AG08 | IT | I | VALID | ||||
| INEBILIZUMAB | L04AG10 | IT | I | 18-11-2022 | EMEA/H/C/005818 | 25-04-2022 | VALID | |
| ANIFROLUMAB | L04AG11 | IT | I | 28-04-2022 | EMEA/H/C/004975 | 14-02-2022 | VALID | |
| OFATUMUMAB | L04AG12 | IT | Not authorised | 01-06-2021 | VALID | |||
| UBLITUXIMAB | L04AG14 | IT | I | 14-11-2023 | EMEA/H/C/005914 | 31-05-2023 | VALID | |
| ROZANOLIXIZUMAB | L04AG16 | IT | I | 13-05-2024 | EMEA/H/C/005824 | 05-01-2024 | VALID | |
| EVEROLIMUS | L04AH02 | IT | I | None | VALID |